Source study found
Story checked
One year after taking ibogaine, veterans find continued relief from PTSD (opens in a new tab)
medicalxpress.com · 2026-10-07
Short answer
Needs reviewStudy found.
We found the study, but the claim check did not finish.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
One year after taking ibogaine, veterans find continued relief from PTSD
medicalxpress.com · 2026-10-07
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We found the study behind this story.
We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.
Open claim evidenceThe source study
Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in special operations veterans with traumatic brain injuries
Evidence layer
Claim by claim
The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedA group of 30 special forces veterans with the psychiatric consequences of multiple traumatic brain injuries traveled to Mexico to undergo ibogaine therapy and were studied by Stanford Medicine researchers before and after treatment.View evidenceHide evidence
As stated30 veterans
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 2 of 6Not checkedIn a study published Aug. 12 in Translational Psychiatry, researchers reported that for most participants the benefits from a single ibogaine treatment appeared to remain robust one year later.View evidenceHide evidence
As statedone year later
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 3 of 6Not checkedIn early 2024, Stanford Medicine researchers reported that of the 23 veterans with a pre-treatment diagnosis of PTSD, 19 achieved remission within days.View evidenceHide evidence
As stated19 of 23 veterans
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 4 of 6Not checkedThe study reported persistent reductions in PTSD, depression, anxiety and functional disability over the course of the year.View evidenceHide evidence
As statedone year
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 5 of 6Not checkedAmong participants who achieved remission soon after treatment, the reported likelihood of sustained remission at 12 months was 84% for PTSD, 66% for depression and 61% for anxiety.View evidenceHide evidence
As stated84% for PTSD, 66% for depression, 61% for anxiety
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 6 of 6Not checkedThe researchers said the study was only observational, and they could not say the one-year effect was due solely to the initial ibogaine experience because some participants had therapy, psychotropic medications, or additional psychedelic use during follow-up.View evidenceHide evidence
As stated11 months of follow-up with additional interventions reported
Not checked
The source study was found, but this claim couldn't be checked against it.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in special operations veterans with traumatic brain injuries
Translational Psychiatry · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, PubMed, Europe PMC · 27 candidate papers
Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in special operations veterans with traumatic brain injuries
Translational Psychiatry · 2026 · Crossref
Psychedelics are associated with changes in spiritual beliefs and orientations in US veterans
2026 · Crossref
Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging · 2026 · PubMed, Europe PMC, Crossref
Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders
Npj Mental Health Research · 2026 · PubMed, Europe PMC, Crossref
Pathophysiology of the Post-Traumatic Confusional State and Post-Traumatic Amnesia: A Scoping Review
Journal of Neurotrauma · 2026 · Crossref
Author Guidelines
Translational Research · 2026 · Crossref
And 21 more candidates considered.